23.49
price down icon5.81%   -1.45
after-market アフターアワーズ: 23.49
loading

Lenz Therapeutics Inc (LENZ) 最新ニュース

pulisher
Feb 21, 2025

LENZ Therapeutics (LENZ) to Release Quarterly Earnings on Wednesday - Defense World

Feb 21, 2025
pulisher
Feb 19, 2025

LENZ Therapeutics Insiders Placed Bullish Bets Worth US$551.1k - Yahoo Finance UK

Feb 19, 2025
pulisher
Feb 18, 2025

Citi maintains Buy on LENZ Therapeutics, target at $44 By Investing.com - Investing.com Canada

Feb 18, 2025
pulisher
Feb 18, 2025

Citi maintains Buy on LENZ Therapeutics, target at $44 - Investing.com

Feb 18, 2025
pulisher
Feb 16, 2025

Mirae Asset Global Investments Co. Ltd. Makes New Investment in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World

Feb 16, 2025
pulisher
Feb 16, 2025

916 Shares in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Acquired by Mirae Asset Global Investments Co. Ltd. - Defense World

Feb 16, 2025
pulisher
Feb 13, 2025

LENZ Therapeutics (NASDAQ:LENZ) Shares Down 4.7%Should You Sell? - MarketBeat

Feb 13, 2025
pulisher
Feb 10, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Acquired by SG Americas Securities LLC - Defense World

Feb 10, 2025
pulisher
Feb 07, 2025

The Presbyopia Market Size to Reach USD 2,513.0 Million by 2035, Impelled by Technological Advancements in Diagnostic Tools - BioSpace

Feb 07, 2025
pulisher
Feb 07, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Feb 07, 2025
pulisher
Feb 06, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives $35.40 Average Target Price from Brokerages - Defense World

Feb 06, 2025
pulisher
Feb 04, 2025

LENZ Therapeutics (NASDAQ:LENZ) Trading 8% HigherWhat's Next? - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Leerink Partnrs Has Negative Outlook of LENZ FY2025 Earnings - MarketBeat

Feb 04, 2025
pulisher
Feb 02, 2025

LENZ Therapeutics (NASDAQ:LENZ) Trading Down 5.1%What's Next? - MarketBeat

Feb 02, 2025
pulisher
Feb 01, 2025

LENZ Therapeutics (LENZ) to Release Earnings on Wednesday - MarketBeat

Feb 01, 2025
pulisher
Feb 01, 2025

Leerink Partnrs Has Pessimistic View of LENZ FY2025 Earnings - Defense World

Feb 01, 2025
pulisher
Jan 31, 2025

More Heart, Less Skin: US FDA’s 2025 Novel Approvals Should Reflect Pipeline Shifts - News & Insights

Jan 31, 2025
pulisher
Jan 30, 2025

Yankuang Energy Group Company Limited (OTCMKTS:YZCAY) Sees Large Decrease in Short Interest - Defense World

Jan 30, 2025
pulisher
Jan 29, 2025

Myopia Pipeline 2024: Detailed Clinical Trials - openPR

Jan 29, 2025
pulisher
Jan 29, 2025

LENZ Therapeutics (LENZ) Expected to Announce Earnings on Wednesday - Defense World

Jan 29, 2025
pulisher
Jan 25, 2025

Barclays PLC Sells 1,835 Shares of Grupo Financiero Galicia S.A. (NASDAQ:GGAL) - Defense World

Jan 25, 2025
pulisher
Jan 23, 2025

Presbyopia Market on Track for Major Expansion by 2034, According to DelveInsight - EIN News

Jan 23, 2025
pulisher
Jan 20, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Sees Significant Increase in Short Interest - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

Lincoln Electric Holdings, Inc. (NASDAQ:LECO) Short Interest Down 5.0% in December - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

LifeVantage Co. (NASDAQ:LFVN) Short Interest Down 5.4% in December - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World

Jan 20, 2025
pulisher
Jan 20, 2025

Morgan Stanley Cuts U.S. Bancorp (NYSE:USB) Price Target to $59.00 - Defense World

Jan 20, 2025
pulisher
Jan 19, 2025

Short Interest in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Expands By 11.9% - MarketBeat

Jan 19, 2025
pulisher
Jan 19, 2025

Barclays PLC Has $391,000 Stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Jan 19, 2025
pulisher
Jan 19, 2025

Barclays PLC Buys 12,051 Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat

Jan 19, 2025
pulisher
Jan 17, 2025

LENZ Therapeutics (NASDAQ:LENZ) Trading Down 5%Time to Sell? - MarketBeat

Jan 17, 2025
pulisher
Jan 14, 2025

Trio-Tech International (NYSE:TRT) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

Harbor Capital Advisors Inc. Buys Shares of 43,989 LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat

Jan 13, 2025
pulisher
Jan 12, 2025

Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) PT at $35.40 - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

Jane Street Group LLC Acquires Shares of 12,027 LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Jan 11, 2025
pulisher
Jan 10, 2025

LENZ Therapeutics (NASDAQ:LENZ) Shares Down 8.9%Here's What Happened - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Intellia stock hurts gene editing after layoffs (NTLA:NASDAQ) - Seeking Alpha

Jan 10, 2025
pulisher
Jan 10, 2025

Lenz Therapeutics New Becomes Oversold (LENZ) - Nasdaq

Jan 10, 2025
pulisher
Jan 10, 2025

Financial Survey: Fresh Tracks Therapeutics (NASDAQ:FRTX) vs. LENZ Therapeutics (NASDAQ:LENZ) - Defense World

Jan 10, 2025
pulisher
Jan 10, 2025

Head to Head Contrast: Allied Resources (ALOD) versus Its Peers - Defense World

Jan 10, 2025
pulisher
Jan 09, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Average Rating of "Buy" from Brokerages - MarketBeat

Jan 09, 2025
pulisher
Jan 08, 2025

Sionna Therapeutics Appoints Dr. Marcella Kuhlman Ruddy and Dr. Jo Viney to its Board of Directors - citybiz

Jan 08, 2025
pulisher
Jan 04, 2025

SkyWater Technology, Inc. (NASDAQ:SKYT) Shares Purchased by Barclays PLC - Defense World

Jan 04, 2025
pulisher
Jan 04, 2025

NI Holdings, Inc. (NASDAQ:NODK) Shares Purchased by Barclays PLC - Defense World

Jan 04, 2025
pulisher
Jan 04, 2025

Barclays PLC Acquires 45,781 Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR) - Defense World

Jan 04, 2025
pulisher
Jan 03, 2025

Geode Capital Management LLC Lowers Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat

Jan 03, 2025
pulisher
Jan 03, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Sold by Geode Capital Management LLC - Defense World

Jan 03, 2025
pulisher
Jan 02, 2025

Neumora plummets on depression drug data - BioPharma Dive

Jan 02, 2025
pulisher
Jan 01, 2025

Companies Like LENZ Therapeutics (NASDAQ:LENZ) Are In A Position To Invest In Growth - Simply Wall St

Jan 01, 2025
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):